2629.0000 4.00 (0.15%)
NSE Nov 19, 2026 15:31 PM
Volume: 209.6K
 

2629.00
0.15%
Motilal Oswal
Mankind’s domestic formulation (DF) business is witnessing a healthy revival, with Mar’26 growth at 11.5% YoY vs. IPM growth at 10.6% (1.1pp outperformance).
Mankind Pharma has gained 15.54% in the last 1 Month
More from Mankind Pharma Lt…
All earning calls
Investor presentations from Mankind Pharma Lt…
All investor presentations